Covalsert Tablet
Valsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
MFDS item code 200807075 · Notified 2008.06.26
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy. It effectively lowers blood pressure and helps reduce the risk of cardiovascular disease. Therefore, it is a suitable treatment option for those who struggle with blood pressure management.
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergic reactions to this medication, severe liver impairment, or kidney impairment should not use it. Caution should be exercised in patients with weak kidney or liver function, as this medication may affect electrolyte balance or kidney function. Elderly patients or those with heart conditions should have their blood pressure and kidney function monitored frequently while taking this medication. There is an increased risk of skin cancer, so sun exposure should be avoided during treatment, and any skin abnormalities should be reported to a doctor. This medication may cause dizziness or drowsiness; therefore, caution is advised when driving or operating machinery. Potassium supplements or potassium-containing medications should not be taken without consulting a physician, and regular monitoring of serum electrolyte levels is necessary. Overdose may result in hypotension, arrhythmias, electrolyte imbalances, etc., so immediate medical attention is required. This medication may interact with various other medications; therefore, inform your doctor or pharmacist if you are taking other medications. It is advisable to avoid using this medication while nursing, and safety in pediatric patients has not been established. This medication should be stored in a tightly sealed container, away from moisture and direct sunlight, and out of the reach of children.
Headache, dizziness, nasopharyngitis, fatigue, back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myofascial strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, oropharyngeal pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, polyuria, palpitations, rash, ligament strain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, asthenia, angioedema, rash, pruritus, serum sickness, vasculitis, hair loss, kidney dysfunction, myalgia, anaphylactic-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, hyponatremia, dizziness, vasculitis, abdominal pain, elevated liver function tests, angioedema, rash, pruritus, vesicular dermatitis, renal failure, hypokalemia, increased serum lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, urticaria, skin rash, photosensitivity reactions, necrotizing vasculitis, erythematosus lupus, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, diarrhea, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, headache, sleep disturbances, depression, paresthesia, visual impairment, leukopenia, agranulocytosis, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, erectile dysfunction, hypersensitivity reaction, pneumonia, pulmonary edema, acute renal failure, kidney dysfunction, aplastic anemia, erythema multiforme, fever, muscle cramps, weakness, acute closed-angle glaucoma, nausea, drowsiness, hypovolemia, arrhythmia, muscle spasms
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature below 30 degrees.
Pink oval film-coated tablet
98 tablets (14 tablets/PTP × 7)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.